News
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...
These five ASX 200 stocks are highly rated by brokers. Let's see what they are recommending as buys after the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback